Pharmacological profile of venlafaxine, a new antidepressant, given acutely.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Polish Journal of Pharmacology

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 9798262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic treatment with antidepressants: Potentiation of clonidine-induced aggression in mice via noradrenergic mechanism

  2005cited by this paper
• Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms.

  1997cited by this paper
• Safety and tolerance profile of venlafaxine

  1995cited by this paper
• Venlafaxine. A review of its pharmacology and therapeutic potential in depression.

  1995cited by this paper
• Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.

  1995cited by this paper
• Binding of antidepressants to human brain receptors: focus on newer generation compounds

  1994cited by this paper
• Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.

  1994cited by this paper
• A comparison of venlafaxine, trazodone, and placebo in major depression.

  1994cited by this paper
• Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.

  1994cited by this paper
• The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.

  1989cited by this paper
• Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.

  1986cited by this paper
• 5‐Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors

  1983cited by this paper
• The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.

  1983cited by this paper
• Imipramine antagonism of apomorphine-induced hypothermia: a non-dopaminergic interaction.

  1978cited by this paper
• Behavioural despair in rats: a new model sensitive to antidepressant treatments.

  1978cited by this paper
• Behavioral despair in mice: a primary screening test for antidepressants.

  1977cited by this paper
• Potentiating effect of lithium chloride on aggressive behavior induced in mice by nialamide plus L-DOPA and by clonidine.

  1975cited by this paper
• The effect of tricyclic antidepressants on apomorphine-induced hypothermia in the mouse.

  1974cited by this paper
• A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

  1963cited by this paper

• The influence of aripiprazole and venlafaxine on the antidepressant-like effect observed in prenatally stressed rats (animal model of depression)

  2018influential citation
• A translational pharmacology approach to understanding the predictive value of abuse potential assessments

  2013cites this paper
• Efecto neurofarmacológico del zumo de Morinda citrifolia

  2011cites this paper
• Neuropharmacological properties of Morinda citrifolia juice)

  2011cites this paper
• Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties

  2005cites this paper
• Antidepressant and Memory Affecting Influence of Estrogen and Venlafaxine in Ovariectomized Rats

  2005cites this paper
• Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.

  2004cites this paper
• The pharmacology of putative early-onset antidepressant strategies.

  2003cites this paper
• Comparison of Behavioural Effects of Venlafaxine and Imipramine in Rats

  2003cites this paper
• [Venlafaxine titration dosage in depressive in-patients. A series of cases].

  2003cites this paper
• Role of neuropeptides in antidepressant and memory improving effects of venlafaxine.

  2002cites this paper
• Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?

  2001cites this paper
• Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the α1-adrenergic, dopamine and serotonin systems

  1999cites this paper
• Pharmacological profile of milnacipran, a new antidepressant, given acutely.

  1999cites this paper
• Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.

  1999cites this paper
• Effects of venlafaxine given repeatedly on α1‐adrenergic, dopaminergic and serotonergic receptors in rat brain

  1999cites this paper